Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
Section snippets
Acknowledgements
This study was partly supported by a grant from the Bundesministerium für Gesundheit to HAK and SP (324-4473-05/3). We gratefully acknowledge the site visiting physicians S. Räcker, S. Grosche, K. Weidehaas and M. Bodemer for technical assistance. We thank Annette Pfahlberg (M.Sc., Department of Medical Statistics, Goettingen) for calculating the confidence intervals. We thank all physicians notifying suspect cases to the German CJD surveillance unit, for providing pertinent clinical,
References (20)
- et al.
The incidence of Creutzfeldt–Jakob disease in Europe in 1993
Lancet
(1994) - et al.
Increased cerebrospinal fluid tau in patients with Alzheimer's disease
Neurosci. Lett.
(1995) - et al.
Cerebrospinal protein tau is elevated in early Alzheimer's disease
Neurosci. Lett.
(1996) - et al.
Diagnosis of Creutzfeldt–Jakob disease by two dimensional gel electrophoresis of cerebrospinal fluid
Lancet
(1996) - et al.
Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt–Jakob disease
Lancet
(1995) - et al.
Tau in cerebrospinal fluid: a potential diagnostic in Alzheimer's disease
Ann. Neurol.
(1995) - et al.
Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease
Ann. Neurol.
(1994) - et al.
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease
Acta Neuropathol.
(1996) Alzheimer's disease and Creutzfeldt–Jakob disease: overlap of pathogenic mechanisms
Curr. Opin. Neurol.
(1993)- et al.
The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.
N. Engl. J. Med.
(1996)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1997 Elsevier Science Ireland Ltd. All rights reserved.